Premium
P3‐101: CROSS‐SECTIONAL BIOMARKER CHARACTERIZATION OF MILD COGNITIVE IMPAIRMENT PATIENTS IN WP5 PHARMACOG/E‐ADNI STUDY
Author(s) -
Galluzzi Samantha,
Marizzoni Moira,
Babiloni Claudio,
BartrésFaz David,
Blin Olivier,
Bordet Regis,
Bosch Beatriz,
Anna Francesca,
Didic Mira,
Farotti Lucia,
Forloni Gianluigi,
Jovicich Jorge,
Marra Camillo,
Marzano Nicola,
Molinuevo Jose Luis,
Nobili Flavio,
Pariente Jeremie,
Parnetti Lucilla,
Payoux Pierre,
Picco Agnese,
Ranjeva JeanPhilippe,
Roccatagliata Luca,
Rossini Paolo Maria,
Salvadori Nicola,
Schönknecht Peter,
Soricelli Andrea,
Tsolaki Magda,
Vecchio Fabrizio,
Visser Pieter Jelle,
Wiltfang Jens,
Frisoni Giovanni
Publication year - 2014
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2014.05.1190
Subject(s) - splenium , medicine , fornix , neuropsychology , corpus callosum , lumbar puncture , audiology , cerebrospinal fluid , psychology , cardiology , hippocampus , cognition , pathology , white matter , magnetic resonance imaging , radiology , psychiatry
CHARACTERIZATION OF MILD COGNITIVE IMPAIRMENT PATIENTS IN WP5 PHARMACOG/ E-ADNI STUDY Samantha Galluzzi, Moira Marizzoni, Claudio Babiloni, David Bartr esFaz, Olivier Blin, Regis Bordet, Beatriz Bosch, Francesca de Anna, Mira Didic, Lucia Farotti, Gianluigi Forloni, Jorge Jovicich, CamilloMarra, NicolaMarzano, Jose LuisMolinuevo, Flavio Nobili, Jeremie Pariente, Lucilla Parnetti, Pierre Payoux, Agnese Picco, Jean-Philippe Ranjeva, Luca Roccatagliata, Paolo Maria Rossini, Nicola Salvadori, Peter Sch€onknecht, Andrea Soricelli, Magda Tsolaki, Fabrizio Vecchio, Pieter Jelle Visser, Jens Wiltfang, Giovanni Frisoni, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy; 2 IRCCS Fatebenefratelli, Brescia, Italy; 3 University of Rome, Rome, Italy; 4 Universitat de Barcelona and IDIBAPS, Barcelona, Spain; Mediterranean Institute of Cognitive Neurosciences, Marseille, France; Universit e Lille 2, UL2, Lille, France; Hospital Clinic Barcelona, Barcelona, Spain; 8 Aix-Marseille Universit e,, Marseille, France; 9 Service de Neurologie et Neuropsychologie, Marseille, France; Ospedale Santa Maria della Misericordia, Perugia, Italy; Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy; 12 University of Trento, Trento, Italy; 13 Catholic University, Rome, Italy; 14 ICN Hospital Clinic i Universitari and Pasqual Maragall Foundation, Barcelona, Spain; Clinical Neurophysiology, Department of Neurosciences, Ophthalmology and Genetics, University of Genoa, Genoa, Italy; 16 Department of Neurology, CMRR and INSERM U825, Toulouse, France; 17 Institut National de la Sant e et de la Recherche M edicale, Toulouse, France; CIC-UPCET, CHU La Timone, AP-HM, UMR CNRS-Universit e de la M editerran ee, Marseille, France; 19 Department of Neuroscience, Ophthalmology and Genetics University of Genoa, Genoa, Italy; University of Leipzig, Leipzig, Germany; Fondazione SDN per la Ricerca e l’Alta Formazione in Diagnostica Nucleare, Naples, Italy; 22 Aristotle University of Thessaloniki, Thessaloniki, Greece; 23 AFaR Association for Biomedical Research, Rome, Italy; Alzheimer Centre VUMC, Maastricht, Netherlands; University of Duisburg-Essen, Essen, Germany; 26 IRCCS Fatebenefratelli, Brescia, Italy. Contact e-mail: sgalluzzi@fatebenefratelli.it